These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37354147)

  • 1. Black Women and Transthyretin Amyloidosis: Insights From the Women's Health Initiative.
    Falk RH; Kattan CG
    JACC Heart Fail; 2023 Sep; 11(9):1200-1202. PubMed ID: 37354147
    [No Abstract]   [Full Text] [Related]  

  • 2. Transthyretin Cardiac Amyloidosis in Black Americans.
    Shah KB; Mankad AK; Castano A; Akinboboye OO; Duncan PB; Fergus IV; Maurer MS
    Circ Heart Fail; 2016 Jun; 9(6):e002558. PubMed ID: 27188913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Outcomes of p.Val142Ile
    Chandrashekar P; Alhuneafat L; Mannello M; Al-Rashdan L; Kim MM; Dungu J; Alexander K; Masri A
    Circ Genom Precis Med; 2021 Oct; 14(5):e003356. PubMed ID: 34461737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Changes in Functional Capacity After TTR Stabilization in Patients With Transthyretin Cardiac Amyloidosis.
    Cuddy SAM
    Circ Heart Fail; 2022 Jul; 15(7):e009387. PubMed ID: 35766044
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure.
    Greulich S; Mahrholdt H; Casadonte R; Steinmüller-Magin L; Latus J; Blessing F; Kriegsmann J; Bekeredjian R; Gawaz M; Klingel K
    Clin Res Cardiol; 2023 Mar; 112(3):444-449. PubMed ID: 35925392
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
    Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
    Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus.
    Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
    Amyloid; 2019; 26(sup1):15-16. PubMed ID: 31343338
    [No Abstract]   [Full Text] [Related]  

  • 8. Serial
    Okada A; Tateishi E; Morita Y; Ohta-Ogo K; Izumi C
    Circ Heart Fail; 2023 Jan; 16(1):e009595. PubMed ID: 36541213
    [No Abstract]   [Full Text] [Related]  

  • 9. A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
    Huda A; Castaño A; Niyogi A; Schumacher J; Stewart M; Bruno M; Hu M; Ahmad FS; Deo RC; Shah SJ
    Nat Commun; 2021 May; 12(1):2725. PubMed ID: 33976166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
    J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-Profiling of Transthyretin Amyloid Cardiomyopathy.
    Mehmood M
    JACC Heart Fail; 2021 May; 9(5):403-404. PubMed ID: 33926733
    [No Abstract]   [Full Text] [Related]  

  • 13. Transthyretin Cardiac Amyloidosis: From Rare Monogenic Disease to Common Pathway in Heart Failure?
    Culotta V; Moon JC
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):888-889. PubMed ID: 27514622
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply: Bio-Profiling of Transthyretin Amyloid Cardiomyopathy.
    Rapezzi C; Sultan MB; Maurer MS
    JACC Heart Fail; 2021 May; 9(5):404. PubMed ID: 33926735
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities.
    Sher T; Velarde GP; Gertz MA
    J Am Coll Cardiol; 2020 Jul; 76(1):93-95. PubMed ID: 32616166
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract]   [Full Text] [Related]  

  • 18. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
    J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy.
    Rowin EJ; Ruberg FL; Das G; Higgins D; Lipe WC; Bokhari N; Dehn M; Maron BJ; Maron MS
    Circ Cardiovasc Imaging; 2022 Dec; 15(12):e014938. PubMed ID: 36448453
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
    JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.